NO993435L - Transdermalt acetylsalicylsyre inneholdende terapeutisk system med forsterket resorpsjon - Google Patents

Transdermalt acetylsalicylsyre inneholdende terapeutisk system med forsterket resorpsjon

Info

Publication number: NO993435L
Authority: NO; Norway
Prior art keywords: acetylsalicylic acid; therapeutic system; transdermal; acid containing; containing therapeutic
Prior art date: 1997-01-15

Application number

NO993435A

Other languages

English (en)

Norwegian (no)

Other versions

NO993435D0 (no

Inventor

Michael Horstmann

Original Assignee

Lohmann Therapie Syst Lts

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-01-15

Filing date

1999-07-12

Publication date

1999-07-12

1999-07-12 Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts

1999-07-12 Publication of NO993435D0 publication Critical patent/NO993435D0/no

1999-07-12 Publication of NO993435L publication Critical patent/NO993435L/no

Links

BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 title abstract 2
229960001138 acetylsalicylic acid Drugs 0.000 title abstract 2
230000001225 therapeutic effect Effects 0.000 title abstract 2
XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 abstract 4
MEJYDZQQVZJMPP-ULAWRXDQSA-N (3s,3ar,6r,6ar)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound CO[C@H]1CO[C@@H]2[C@H](OC)CO[C@@H]21 MEJYDZQQVZJMPP-ULAWRXDQSA-N 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 2
229940087305 limonene Drugs 0.000 abstract 2
235000001510 limonene Nutrition 0.000 abstract 2
239000010410 layer Substances 0.000 abstract 1
239000011241 protective layer Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO993435A 1997-01-15 1999-07-12 Transdermalt acetylsalicylsyre inneholdende terapeutisk system med forsterket resorpsjon NO993435L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19701059A DE19701059C2 (de)	1997-01-15	1997-01-15	Acetylsalicylsäure enthaltendes transdermales therapeutisches System mit Resorptionsverstärkung
PCT/EP1998/000013 WO1998031348A1 (fr)	1997-01-15	1998-01-03	Systeme therapeutique transdermique contenant de l'acide acetylsalicylique a resorption renforcee

Publications (2)

Publication Number	Publication Date
NO993435D0 NO993435D0 (no)	1999-07-12
NO993435L true NO993435L (no)	1999-07-12

Family

ID=7817375

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO993435A NO993435L (no)	1997-01-15	1999-07-12	Transdermalt acetylsalicylsyre inneholdende terapeutisk system med forsterket resorpsjon

Country Status (8)

Country	Link
EP (1)	EP1023053A1 (fr)
JP (1)	JP2001508069A (fr)
KR (1)	KR20000070228A (fr)
AU (1)	AU726094B2 (fr)
CA (1)	CA2277366A1 (fr)
DE (1)	DE19701059C2 (fr)
NO (1)	NO993435L (fr)
WO (1)	WO1998031348A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19949202A1 (de) *	1999-10-13	2001-05-03	Lohmann Therapie Syst Lts	Transdermales therapeutisches System zur Abgabe von Acetylsalicylsäure und/oder Salicylsäure
DE19949252B4 (de) *	1999-10-13	2004-02-12	Lts Lohmann Therapie-Systeme Ag	Verwendung eines superfiziellen therapeutischen Systems zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen und Verfahren zu seiner Herstellung
DE19959913A1 (de) *	1999-12-11	2001-06-28	Lohmann Therapie Syst Lts	Acetylsalicylsäure enthaltendes transdermales System zur Behandlung von Migräne
KR100448469B1 (ko) *	2001-10-26	2004-09-13	신풍제약주식회사	항염증제의 경피 조성물 및 장치
TW200300696A (en)	2001-11-01	2003-06-16	Inhale Therapeutic Syst	Spray drying methods and related compositions
DE10338162B3 (de) †	2003-08-20	2005-06-02	Haldex Brake Products Gmbh	Verfahren zum Betreiben einer Druckluftbeschaffungsanlage eines Kraftfahrzeuges sowie Druckluftaufbereitungseinrichtung
DE102005033543A1 (de) *	2005-07-14	2007-01-18	Grünenthal GmbH	Ein einen Duftstoff aufweisendes transdermales therapeutisches System
DE102005050431A1 (de)	2005-10-21	2007-04-26	Lts Lohmann Therapie-Systeme Ag	Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe
IT202000014578A1 (it) *	2020-06-18	2021-12-18	Poli Md S R L	Dispositivo medicale comprendente acido acetil salicilico

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4228162A (en) *	1979-07-09	1980-10-14	Research Corporation	Dimethyl isosorbide in liquid formulation of aspirin
US5164416A (en) *	1989-02-03	1992-11-17	Lintec Corporation	Transdermal therapeutic formulation containing a limonene
DE4332093C2 (de) *	1993-09-22	1995-07-13	Lohmann Therapie Syst Lts	Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung
DE4332094C2 (de) *	1993-09-22	1995-09-07	Lohmann Therapie Syst Lts	Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung

1997
- 1997-01-15 DE DE19701059A patent/DE19701059C2/de not_active Expired - Fee Related
1998
- 1998-01-03 CA CA002277366A patent/CA2277366A1/fr not_active Abandoned
- 1998-01-03 AU AU59862/98A patent/AU726094B2/en not_active Ceased
- 1998-01-03 KR KR1019997006454A patent/KR20000070228A/ko not_active Withdrawn
- 1998-01-03 WO PCT/EP1998/000013 patent/WO1998031348A1/fr not_active Ceased
- 1998-01-03 EP EP98902976A patent/EP1023053A1/fr not_active Withdrawn
- 1998-01-03 JP JP53137698A patent/JP2001508069A/ja active Pending
1999
- 1999-07-12 NO NO993435A patent/NO993435L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE19701059C2 (de)	2000-12-21
AU5986298A (en)	1998-08-07
JP2001508069A (ja)	2001-06-19
EP1023053A1 (fr)	2000-08-02
AU726094B2 (en)	2000-11-02
DE19701059A1 (de)	1998-07-16
CA2277366A1 (fr)	1998-07-23
NO993435D0 (no)	1999-07-12
WO1998031348A1 (fr)	1998-07-23
KR20000070228A (ko)	2000-11-25

Similar Documents

Publication	Publication Date	Title
FI953533L (fi)	1995-07-21	Transdermaalinen terapeuttinen järjestelmä, jossa on galantamiinia vaikuttavana aineena
IT1283102B1 (it)	1998-04-07	Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
FI961282L (fi)	1996-05-17	Transdermaalinen terapeuttinen systeemi, jossa on asetyylisalisyylihappo vaikuttavana aineena
NO971206D0 (no)	1997-03-14	Forlenget-frigjöringsformulering
ATE121302T1 (de)	1995-05-15	Transdermales therapeutisches system mit dem wirkstoff tulobuterol.
DE19680582D2 (de)	1998-10-29	Hormonpflaster
IT1230742B (it)	1991-10-29	Composizione per aerosol comprendente nitroglicerina come ingrediente attivo.
WO2002003969A3 (fr)	2002-05-23	Systeme therapeutique transdermique contenant du dioxyde de silicium fortement disperse
NO962933L (no)	1996-09-12	Östradiol-penetrasjonsforsterker for transdermal administrering
DK0697859T3 (da)	1997-12-29	Stabile, orale og absorberbare terapeutiske præparater af NADP og NADPH
FI954990L (fi)	1995-11-23	Aktiiviainetta sisältävä transdermaalinen valmiste
DK0825178T3 (da)	2001-09-03	Phenylsubstituerede alkenylcarboxylsyreguanidider, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf
NO970610L (no)	1997-03-21	Sammensetning for selektiv frigjöring av en aktiv ingrediens
FI954497A7 (fi)	1995-09-22	Aktiivista ainetta sisältävä laastari estradiolin vapauttamiseksi ihoo n
FI950165A7 (fi)	1995-01-13	Ihon läpäisevä terapeuttinen järjestelmä, jossa vaikuttavana aineena o n 17-beta-estradioli (vedetön)
DK0994696T3 (da)	2004-06-01	Farmaceutisk præparat til kontrolleret frigörelse med indhold af ACE-hæmmer som aktivt stof
WO2001026637A3 (fr)	2001-12-13	Systeme therapeutique transdermique permettant de delivrer de l'acide acetylsalicylique et/ou de l'acide salicylique
NO306060B1 (no)	1999-09-13	Substituerte kanelsyreguanidider, deres anvendelse samt medikamenter inneholdende guanididene
FI900315A0 (fi)	1990-01-19	Saett att framstaella ett ytligt terapeutiskt system vilket innehaoller tillvaext av elakartade celler och tillvaextfoerhindrande aktivaemne, speciellt 5-fluoruracil.
DK0634396T3 (da)	1999-07-05	Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
NO985807D0 (no)	1998-12-11	Transdermale systemer inneholdende 2 aktive ingredienser i separate seksjoner, deres fremstillingsprosess og deres anvendelse som medikament
NO993435D0 (no)	1999-07-12	Transdermalt acetylsalicylsyre inneholdende terapeutisk system med forsterket resorpsjon
DK1062954T3 (da)	2007-09-10	Anvendelse af itakonsyre til regulering af det glykotiske stofskifte
WO2001041771A3 (fr)	2001-12-27	Systeme transdermique contenant de l'acide acetylsalicylique pour le traitement de la migraine
PL332035A1 (en)	1999-08-16	Transdermal therapeutic system including an estriol-containing composition of active substances

Legal Events

Date	Code	Title	Description
2001-07-23	FC2A	Withdrawal, rejection or dismissal of laid open patent application